Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Traphaco Sapa is a prominent Vietnamese pharmaceutical company and a key subsidiary of Traphaco JSC, specializing in the cultivation, processing, and manufacturing of herbal medicines. Located in the biodiverse Sapa region, the company leverages local medicinal plant resources to produce high-quality traditional and herbal-based pharmaceuticals. Its operations are centered on GACP-WHO (Good Agricultural and Collection Practices) standards for raw materials and GMP-WHO standards for manufacturing. Traphaco Sapa is best known for providing the core herbal ingredients for blockbuster Vietnamese products such as Boganic and various brain circulation supplements. The company plays a vital role in the sustainable development of medicinal herbs in Northern Vietnam, integrating ethnic minority knowledge with modern pharmaceutical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Traphacosapa.